Company Overview and News


Add PAA
to your dashboard

Headline News

PharmAust wins European patent for its cancer therapy drug

2017-09-16 proactiveinvestors.com.au
PharmAust Limited (ASX:PAA) has received a patent in Europe for the use of its lead drug monepantel (MPL) as a cancer therapy with intellectual property (IP) protection until 2033.

PharmAust secures Australian patent for non-cancer applications

2017-05-17 proactiveinvestors.com.au
PharmAust (ASX:PAA) has been granted a new patent in Australia extending the use of its lead drug for non-cancer applications, including neurodegenerative diseases, diabetes and age-related disorders.

PharmAust Ltd ships reformulated capsules to begin canine cancer trials

2016-09-13 proactiveinvestors.com.au
PharmAust Ltd (ASX:PAA) has shipped 2,000 newly formulated capsules of anticancer drug candidate monepantel (MPL) to enable canine cancer trials to begin at two centres. The Animal Referral Hospital at Homebush, New South Wales and the Queensland Veterinary Specialists in Brisbane will each receive 1000 capsules of MPL. Previous studies have demonstrated that tumour marker p70s6k was meaningfully suppressed in both humans and canines following treatment with MPL.

PharmAust Ltd to begin canine cancer trials

2016-08-10 proactiveinvestors.com.au
PharmAust Ltd (ASX:PAA) is a pharmaceutical company involved in a range of activities, from contract drug discovery and development, to manufacturing, sales, and marketing of healthcare and pharmaceutical products.

PharmAust Ltd to start Phase II canine cancer trial in the UK

2016-07-11 proactiveinvestors.com.au
PharmAust Ltd (ASX:PAA) is a pharmaceutical company involved in a range of activities, from contract drug discovery and development, to manufacturing, sales, and marketing of healthcare and pharmaceutical products.

PharmAust Ltd in canine cancer trial at Cambridge University

2016-06-27 proactiveinvestors.com.au
PharmAust Ltd (ASX:PAA) is a pharmaceutical company involved in a range of activities, from contract drug discovery and development, to manufacturing, sales, and marketing of healthcare and pharmaceutical products.